All Stories

  1. HIV-1 control in vivo is related to the number but not the fraction of infected cells with viral unspliced RNA
  2. Widespread expression of the ancient HERV-K (HML-2) provirus group in normal human tissues
  3. HIV proviral DNA integration can drive T cell growth ex vivo
  4. Mechanisms of HERV-K (HML-2) Transcription during Human Mammary Epithelial Cell Transformation
  5. RNA editing, epitranscriptomics, and processing in cancer progression
  6. A Mouse Strain Defective in Both T Cells and NK Cells Has Enhanced Sensitivity to Tumor Induction by Plasmid DNA Expressing Both Activated H-Ras and c-Myc
  7. The distribution of insertionally polymorphic endogenous retroviruses in breast cancer patients and cancer-free controls
  8. HIV-1 Infection Leads to Increased Transcription of Human Endogenous Retrovirus HERV-K (HML-2) Proviruses In Vivo but Not to Increased Virion Production
  9. PAPNC, a novel method to calculate nucleotide diversity from large scale next generation sequencing data
  10. Retrovirus Variation and Evolution
  11. Lack of Detectable HIV-1 Molecular Evolution during Suppressive Antiretroviral Therapy
  12. Endogenous Retroviruses and Human Cancer: Is There Anything to the Rumors?
  13. Fifteen Years Later: Hard and Soft Selection Sweeps Confirm a Large Population Number for HIV In Vivo
  14. False-Positive HIV PCR Test Following Ex Vivo Lentiviral Gene Transfer Treatment of X-linked Severe Combined Immunodeficiency Vector
  15. The distribution of insertionally polymorphic endogenous retroviruses in breast cancer patients and cancer-free controls
  16. A Novel Recombinant Retrovirus in the Genomes of Modern Birds Combines Features of Avian and Mammalian Retroviruses
  17. Single Cell Analysis of Lymph Node Tissue from HIV-1 Infected Patients Reveals that the Majority of CD4+ T-cells Contain One HIV-1 DNA Molecule
  18. Virions at the Gates: Receptors and the Host–Virus Arms Race
  19. Analysis of 454 sequencing error rate, error sources, and artifact recombination for detection of Low-frequency drug resistance mutations in HIV-1 DNA
  20. HIV Population Dynamics
  21. Betaretroviral Envelope Subunits Are Noncovalently Associated and Restricted to the Mammalian Class
  22. HIV-1 Pathogenesis: The Virus
  23. A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus
  24. Ultrasensitive Allele-Specific PCR Reveals Rare Preexisting Drug-Resistant Variants
  25. Recombinant origin, contamination, and de-discovery of XMRV
  26. Studies on the Restriction of Murine Leukemia Viruses by Mouse APOBEC3
  27. Multiple Sources of Contamination in Samples from Patients Reported to Have XMRV Infection
  28. Restricted Replication of Xenotropic Murine Leukemia Virus-Related Virus in Pigtailed Macaques
  29. From XMRV to HIV-1 and back
  30. Characterization, mapping and distribution of the two XMRV parental proviruses
  31. Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
  32. Correction: The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
  33. Multi-laboratory evaluations of XMRV nucleic acid detection assays
  34. The Blood Xenotropic Murine Leukemia Virus-Related Virus Scientific Research Working Group: mission, progress, and plans
  35. Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses
  36. Binding of more than one Tva800 molecule is required for ASLV-A entry
  37. Endogenous Murine Leukemia Viruses: Relationship to XMRV and Related Sequences Detected in Human DNA Samples
  38. ART did not decrease genetic diversity of RT-SHIV
  39. The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
  40. Patterns of Human Immunodeficiency Virus Type 1 Recombination Ex Vivo Provide Evidence for Coadaptation of Distant Sites, Resulting in Purifying Selection for Intersubtype Recombinants during Replication
  41. Multi-site adaptation in the presence of infrequent recombination
  42. Interpreting the effect of vaccination on steady state infection in animals challenged with Simian immunodeficiency virus
  43. CPSF6 binds HIV-1 capsid and cytoplasmic expression restricts infection
  44. Optimization of allele-specific PCR using patient-specific HIV consensus sequences for primer design
  45. Antiretroviral Intensification and Valproic Acid Lack Sustained Effect on Residual HIV-1 Viremia or Resting CD4+ Cell Infection
  46. Low Frequency Nonnucleoside Reverse‐Transcriptase Inhibitor–Resistant Variants Contribute to Failure of Efavirenz‐Containing Regimens in Treatment‐Experienced Patients
  47. Endogenous non-retroviral RNA virus elements in mammalian genomes
  48. Mouse DNA contamination in human tissue tested for XMRV
  49. Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences
  50. RT-SHIV subpopulation dynamics in infected macaques during anti-HIV therapy
  51. A New Virus for Old Diseases?
  52. Persistent Low‐Level Viremia in HIV‐1 Elite Controllers and Relationship to Immunologic Parameters
  53. Evaluation of the Pathogenesis of Decreasing CD4 + T Cell Counts in Human Immunodeficiency Virus Type 1–Infected Patients Receiving Successfully Suppressive Antiretroviral Therapy
  54. Likely Role of APOBEC3G-Mediated G-to-A Mutations in HIV-1 Evolution and Drug Resistance
  55. Regimen Simplification to Atazanavir‐Ritonavir Alone as Maintenance Antiretroviral Therapy: Final 48‐Week Clinical and Virologic Outcomes
  56. Human Immunodeficiency Virus Type 1 Population Genetics and Adaptation in Newly Infected Individuals
  57. Effects of Retroviruses on Host Genome Function
  58. Attenuation by a Thousand Cuts
  59. Host-Retrovirus Arms Race: Trimming the Budget
  60. Detection of Nonnucleoside Reverse‐Transcriptase Inhibitor–Resistant HIV‐1 after Discontinuation of Virologically Suppressive Antiretroviral Therapy
  61. Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells
  62. Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase
  63. Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction
  64. Study of RT inhibitor resistance in a macaque model of HIV/AIDS
  65. Retroviruses and AIDS: evolution and drug resistance
  66. Role of APOBEC3 in Genetic Diversity among Endogenous Murine Leukemia Viruses
  67. ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia
  68. Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy
  69. Depletion of latent HIV-1 infection in vivo: a proof-of-concept study
  70. Characterization of Hortulanus Endogenous Murine Leukemia Virus, an Endogenous Provirus That Encodes an Infectious Murine Leukemia Virus of a Novel Subgroup
  71. Symmetrical base preferences surrounding HIV-1, avian sarcoma/leukosis virus, and murine leukemia virus integration sites
  72. Multiple, Linked Human Immunodeficiency Virus Type 1 Drug Resistance Mutations in Treatment-Experienced Patients Are Missed by Standard Genotype Analysis
  73. Role of APOBEC3 in Genetic Diversity among Endogenous Murine Leukemia Viruses
  74. SIV containing HIV-1 RT can be inhibited by anti-HIV-1 RT inhibitors
  75. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome
  76. New Real-Time Reverse Transcriptase-Initiated PCR Assay with Single-Copy Sensitivity for Human Immunodeficiency Virus Type 1 RNA in Plasma
  77. A Novel Endogenous Retrovirus-Related Element in the Human Genome Resembles a DNA Transposon: Evidence for an Evolutionary Link?
  78. Mouse Mammary Tumor Virus Superantigen Expression Is Reduced by Glucocorticoid Treatment
  79. The Mouse Mammary Tumor Virus Transcription Enhancers for Hematopoietic Progenitor and Mammary Gland Cells Share Functional Elements
  80. Proposed alternatives for the use of anti-HIV drugs: is it appropriate?
  81. Book Review Microbe Hunters — Then and now Edited by Hilary Koprowski and Michael B.A. Oldstone. 456 pp., illustrated. Bloomington, Ill., Medi-Ed Press, 1996. $45. 0-936741-11-2
  82. Workshop Summary : Workshop on Perinatally Acquired Human Immunodeficiency Virus Infection in Long-Term Surviving Children: A Collaborative Study of Factors Contributing to Slow Disease Progression
  83. Retrovirus restriction revealed
  84. The dangers of xenotransplantation
  85. Stimulation of mouse mammary tumor virus superantigen expression by an intragenic enhancer.
  86. Lines drawn in epitope wars
  87. Multifactorial inheritance of neural tube defects: localization of the major gene and recognition of modifiers in ct mutant mice
  88. How does variation count?
  89. Mapping of the motor neuron degeneration (Mnd) gene, a mouse model of amyotrophic lateral sclerosis (ALS)
  90. Mechanism of transduction by retroviruses
  91. Superantigens and endogenous retroviruses: a confluence of puzzles
  92. Structure and Classification of Retroviruses
  93. Characterization of the endogenous nonecotropic murine leukemia viruses of NZB/BINJ and SM/J inbred strains
  94. Book Review Virus Hunting: AIDS, cancer, and the human retrovirus By Robert Gallo. 352 pp., illustrated. New York, Basic Books, 1991. $22.95.
  95. Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice
  96. Isotype switching of an immunoglobulin heavy chain transgene occurs by DNA recombination between different chromosomes
  97. Molecular mechanisms of nucleic acid integration
  98. The virology of AIDS
  99. Genetic Variation in Retroviruses
  100. Determination of 3′ end processing in retroelements
  101. Genetics of Endogenous Murine Leukemia Viruses
  102. Too high a price
  103. Role of endogenous retroviruses as mutagens: The hairless mutation of mice
  104. Highly preferred targets for retrovirus integration
  105. Rous sarcoma virus is integrated but not expressed in chicken early embryonic cells.
  106. Genetic variation in AIDS viruses
  107. Microbiology: The Microbe 1984.
  108. Genomes of endogenous and exogenous avian retroviruses
  109. VARIATION IN AVIAN RETROVIRUS GENOMES
  110. Structural Analysis of Retrovirus Genomes
  111. VIRAL ENVELOPE GENES AND c REGIONS IN NON-ACUTE AVIAN LEUKOSIS VIRUS ASSOCIATED DISEASE
  112. SYNTHESIS AND PROCESSING OF THE INTERNAL STRUCTURAL PROTEINS OF RETROVIRUSES: SITE OF SYNTHESIS, EVIDENCE FOR MULTIPLY-CHARGED SPECIES, AND ANALYSIS OF A MUTANT DEFECTIVE IN PROCESSING11This research supported by grants from the National Cancer Institu...
  113. Subgroup-E Avian-leukosis-virus-associated Disease in Chickens
  114. Recombination between the defective component of an acute leukemia virus and Rous associated virus O, an endogenous virus of chickens.
  115. In Vitro Studies of the Replication of Moloney Murine Leukemia Virus
  116. Recombinant avian oncoviruses I. Alterations in the precursor to the internal structural proteins
  117. Structure of the genome of moloney murine leukemia virus: a terminally redundant sequence
  118. Nucleotide sequence of Rous sarcoma virus RNA at the initiation site of DNA synthesis
  119. The genome of Uukuniemi virus consists of three unique RNA segments
  120. Terminal redundancy and the origin of replication of Rous sarcoma virus RNA.
  121. A physical map of the Rous sarcoma virus genome
  122. The Nucleotide Sequence Complexity of Avian Tumor Virus RNA
  123. In Vitro Synthesis of Rous Sarcoma Virus-Specific RNA is Catalyzed by a DNA-Dependent RNA Polymerase
  124. A new approach to the isolation of RNA-DNA hybrids and its application to the quantitative determination of labeled tumor virus RNA
  125. Retroviruses